Treatment of pediatric anxiety disorders

Amy Rapp, Alice Dodds, John T. Walkup, Moira Rynn*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.

Original languageEnglish (US)
Pages (from-to)52-61
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume1304
Issue number1
DOIs
StatePublished - Jan 1 2013

Keywords

  • Anxiety
  • Cognitive behavioral therapy
  • Pediatric
  • Pharmacotherapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Fingerprint Dive into the research topics of 'Treatment of pediatric anxiety disorders'. Together they form a unique fingerprint.

Cite this